Good Sense Levocetirizine Tablet, Film Coated
NDC Package 0113-0241-01
Package Information
Good Sense Levocetirizine (levocetirizine dihydrochloride) tablets is levocetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. This formulation utilizes a tablet, film coated delivery system. Marketed by L. Perrigo Company, this product is identified by NDC 0113-0241 and is authorized under FDA application ANDA211983.
Identification & Billing
- RxCUI: 855172 - levocetirizine dihydrochloride 5 MG Oral Tablet
- RxCUI: 855172 - levocetirizine dihydrochloride 5 MG 24 HR Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0113 - L. Perrigo Company
- 0113-0241 - Good Sense Levocetirizine
- 0113-0241-01 - 1 BOTTLE in 1 CARTON / 35 TABLET, FILM COATED in 1 BOTTLE
- 0113-0241 - Good Sense Levocetirizine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0113-0241-01 identifies a specific commercial package of 1 bottle in 1 carton / 35 tablet, film coated in 1 bottle of Good Sense Levocetirizine, a human over the counter drug labeled by L. Perrigo Company. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This tablet, film coated is formulated for oral use and contains levocetirizine dihydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by L. Perrigo Company on September 11, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Levocetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. It is also used to relieve itching and hives. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Levocetirizine does not prevent hives or prevent/treat a serious allergic reaction (such as anaphylaxis). If your doctor has prescribed epinephrine to treat allergic reactions, always carry your epinephrine injector with you. Do not use levocetirizine in place of your epinephrine.
How is this L. Perrigo Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00113024101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.